Compare · CDW vs WGS
CDW vs WGS
Side-by-side comparison of CDW Corporation (CDW) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDW and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- CDW is the larger of the two at $16.98B, about 7.4x WGS ($2.30B).
- Over the past year, CDW is down 15.3% and WGS is down 30.1% - CDW leads by 14.8 points.
- CDW has been more active in the news (7 items in the past 4 weeks vs 6 for WGS).
- CDW has more recent analyst coverage (25 ratings vs 8 for WGS).
- Company
- CDW Corporation
- GeneDx Holdings Corp.
- Price
- $135.62-4.46%
- $77.19+10.71%
- Market cap
- $16.98B
- $2.30B
- 1M return
- -3.23%
- +11.21%
- 1Y return
- -15.30%
- -30.09%
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2013
- 2020
- News (4w)
- 7
- 6
- Recent ratings
- 25
- 8
CDW Corporation
CDW Corporation provides integrated information technology (IT) solutions to business, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. It operates through three segments: Corporate, Small Business, and Public. The company offers discrete hardware and software products, as well as integrated IT solutions, including on-premise, hybrid and cloud capabilities across data center and networking, digital workspace, security, and virtualization. Its hardware products comprise notebooks/mobile devices, network communications, desktop computers, video monitors, enterprise and data storage, and other hardware; and software products include application suites, security, virtualization, operating systems, and network management. The company also provides field services, managed services, warranties, configuration services, partner services, and telecom services. CDW Corporation was founded in 1984 and is based in Lincolnshire, Illinois.
Latest CDW
- SEC Form 10-Q filed by CDW Corporation
- CDW Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- CDW Announces CFO Transition
- CDW Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- CDW Declares Quarterly Cash Dividend of $0.630 Per Share
- CDW Reports Second Quarter 2026 Earnings
- CDW to Announce Second Quarter 2026 Results on August 5
- Director Nelms David W was granted 229 shares, increasing direct ownership by 0.45% to 51,415 units (SEC Form 4)
- Director Swedish Joseph was granted 208 shares, increasing direct ownership by 1% to 20,202 units (SEC Form 4)
- CDW upgraded by Morgan Stanley with a new price target
Latest WGS
- Amendment: SEC Form SCHEDULE 13G/A filed by GeneDx Holdings Corp.
- GeneDx to Participate in Upcoming Investor Conferences
- SEC Form 10-Q filed by GeneDx Holdings Corp.
- GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GeneDx Reports Second Quarter 2026 Financial Results
- SEC Form 25-NSE filed by GeneDx Holdings Corp.
- GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026
- SEC Form 4 filed by President Gardner Mark A
- Director Ryan Jason converted options into 3,576 shares, increasing direct ownership by 30% to 15,480 units (SEC Form 4)
- Director Ruch Joshua converted options into 3,576 shares, increasing direct ownership by 12% to 33,299 units (SEC Form 4)